SUBSCRIBE
SUBSCRIBE

Foresee Pharmaceuticals

IN THE PRESS
Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50mg
July 27, 2020
 · 
2 min read
Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg
March 29, 2019
 · 
2 min read
Drug Development
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer
February 21, 2019
 · 
3 min read
Business
Foresee Pharmaceuticals Enters Exclusive License Agreement with Accord Healthcare
February 11, 2019
 · 
3 min read
Load More
JOBS